Latest Insider Transactions at Viking Therapeutics, Inc. (VKTX)
This section provides a real-time view of insider transactions for Viking Therapeutics, Inc. (VKTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Viking Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Viking Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 04
2021
|
Greg Zante Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,787
-2.99%
|
$13,935
$5.8 P/Share
|
|
Jan 04
2021
|
Greg Zante Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
71,450
+24.77%
|
-
|
|
Jan 04
2021
|
Michael Morneau VP, Finance and Administration |
SELL
Payment of exercise price or tax liability
|
Direct |
2,739
-2.27%
|
$13,695
$5.8 P/Share
|
|
Jan 04
2021
|
Michael Morneau VP, Finance and Administration |
BUY
Grant, award, or other acquisition
|
Direct |
21,334
+8.33%
|
-
|
|
Jan 04
2021
|
Brian Lian President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
16,973
-0.89%
|
$84,865
$5.8 P/Share
|
|
Jan 04
2021
|
Brian Lian President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
204,333
+5.05%
|
-
|
|
Jan 03
2021
|
Brian Lian President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
31,545
-1.81%
|
$157,725
$5.63 P/Share
|